关注
Jittasak (Jake) Khowsathit
Jittasak (Jake) Khowsathit
Postdoctoral Associate, Fox Chase Cancer Center
在 fccc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Targeting CDK9 reactivates epigenetically silenced genes in cancer
H Zhang, S Pandey, M Travers, H Sun, G Morton, J Madzo, W Chung, ...
Cell 175 (5), 1244-1258. e26, 2018
2022018
Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase
CE Keohane, AD Steele, C Fetzer, J Khowsathit, D Van Tyne, L Moynié, ...
Journal of the American Chemical Society 140 (5), 1774-1782, 2018
722018
DARC: mapping surface topography by ray-casting for effective virtual screening at protein interaction sites
R Gowthaman, SA Miller, S Rogers, J Khowsathit, L Lan, N Bai, ...
Journal of medicinal chemistry 59 (9), 4152-4170, 2016
262016
Target-based design of promysalin analogues identifies a new putative binding cleft in succinate dehydrogenase
SJ Post, CE Keohane, LM Rossiter, AR Kaplan, J Khowsathit, K Matuska, ...
ACS infectious diseases 6 (6), 1372-1377, 2020
122020
Computational design of an allosteric antibody switch by deletion and rescue of a complex structural constellation
J Khowsathit, A Bazzoli, H Cheng, J Karanicolas
ACS Central Science 6 (3), 390-403, 2020
92020
Modulating antibody structure and function through directed mutations and chemical rescue
CE Kaiser, JP Rincon Pabon, J Khowsathit, MP Castaldi, SL Kazmirski, ...
ACS synthetic biology 7 (4), 1152-1162, 2018
72018
Correction to “Target-Based Design of Promysalin Analogs Identifies a New Putative Binding Cleft in Succinate Dehydrogenase”
SJ Post, CE Keohane, LM Rossiter, AR Kaplan, J Khowsathit, K Matuska, ...
ACS Infectious Diseases 8 (7), 1376-1376, 2022
12022
Target-Based Design of Promysalin Analogs Identifies a New Putative Binding Cleft in Succinate Dehydrogenase (vol 6, pg 1372, 2020)
SJ Post, CE Keohane, LM Rossiter, AR Kaplan, J Khowsathit, K Matuska, ...
ACS INFECTIOUS DISEASES 8 (7), 2022
2022
Compositions and methods for modulation of antibody activity
J Karanicolas, J Khowsathit, DP Yeggoni
US Patent App. 17/600,831, 2022
2022
Using Chemical Biology to Modulate Antibody Activity
J Khowsathit
University of Kansas, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–10